McCain on AI drug IP

Comment: The Molecule Came from AI. The Inventor Still Has to Be Human

ACS Committee Chair Christine E. McCain comments on intellectual property challenges in AI-driven drug discovery, asserting that human inventors remain essential for patent applications despite AI gen